USA - NASDAQ:TGTX - US88322Q1085 - Common Stock
Overall TGTX gets a fundamental rating of 5 out of 10. We evaluated TGTX against 534 industry peers in the Biotechnology industry. TGTX has an average financial health and profitability rating. TGTX is not priced too expensively while it is growing strongly. Keep and eye on this one!
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 8.6% | ||
| ROE | 21.87% | ||
| ROIC | 12.78% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 18.91% | ||
| PM (TTM) | 13.31% | ||
| GM | 86.96% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.89 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 6.43 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.86 | ||
| Quick Ratio | 2.96 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 93.38 | ||
| Fwd PE | 18.21 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 60.73 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
34.55
+0.86 (+2.55%)
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 93.38 | ||
| Fwd PE | 18.21 | ||
| P/S | 12.07 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 19.83 | ||
| P/tB | 19.83 | ||
| EV/EBITDA | 60.73 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 8.6% | ||
| ROE | 21.87% | ||
| ROCE | 16.18% | ||
| ROIC | 12.78% | ||
| ROICexc | 24.32% | ||
| ROICexgc | 24.32% | ||
| OM | 18.91% | ||
| PM (TTM) | 13.31% | ||
| GM | 86.96% | ||
| FCFM | N/A |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.89 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 2.85 | ||
| Cap/Depr | N/A | ||
| Cap/Sales | N/A | ||
| Interest Coverage | 3.33 | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 3.86 | ||
| Quick Ratio | 2.96 | ||
| Altman-Z | 6.43 |
ChartMill assigns a fundamental rating of 5 / 10 to TGTX.
ChartMill assigns a valuation rating of 5 / 10 to TG THERAPEUTICS INC (TGTX). This can be considered as Fairly Valued.
TG THERAPEUTICS INC (TGTX) has a profitability rating of 6 / 10.
The Price/Earnings (PE) ratio for TG THERAPEUTICS INC (TGTX) is 93.38 and the Price/Book (PB) ratio is 19.83.
The financial health rating of TG THERAPEUTICS INC (TGTX) is 4 / 10.